Global Colorectal Cancer Drugs Market Report 2024

Colorectal Cancer Drugs Global Market Report 2024 – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL– Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators), By Class (Immunotherapy, Chemotherapy, Other Classes), By Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

Colorectal Cancer Drugs Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Colorectal Cancer Drugs Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Colorectal Cancer Drugs Market Definition

Colorectal cancer (CRC) or bowel cancer, is a type of cancer affecting the large intestine and the rectum. Depending on where they begin, they are also known as colon tumours or rectal cancer.

The main types of colorectal cancer drugs are vascular endothelial growth factor (VEGF) inhibitors, epidermal growth factor receptor (EGFR) inhibitors, and programmed cell death protein 1/PD1 ligand 1 (PD1/PDL1) inhibitors, BRAF or MEK inhibitors, tyrosine kinase (TKI) inhibitors, and immunomodulators. Vascular endothelial growth factors (VEGF) are drugs that block VEGF and VEGFR activity. The various classes of drugs include immunotherapy, chemotherapy, and others that are distributed by hospitals pharmacies, retail pharmacies, and others.

Colorectal Cancer Drugs Market Segmentation

The colorectal cancer drugs market covered in this report is segmented –

1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators

2) By Class: Immunotherapy, Chemotherapy, Other Classes

3) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels

Global Colorectal Cancer Drugs Market Size 2023 to 2028: Graph

Colorectal Cancer Drugs Market Size 2024 And Growth Rate

The colorectal cancer drugs market size has grown strongly in recent years. It will grow from $19.51 billion in 2023 to $20.74 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to integration of multimodal approaches, introduction of chemotherapy, advancements in surgical techniques, emergence of targeted therapies, clinical trials and research.

Colorectal Cancer Drugs Market Growth Forecast

The colorectal cancer drugs market size is expected to see strong growth in the next few years. It will grow to $26.39 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rise in personalized treatment, patient-centric care models, expansion of targeted therapies, adoption of combination therapies, regulatory acceleration. Major trends in the forecast period include immunotherapy advancements, precision medicine evolution, combination therapies, biomarker research and use, clinical trials innovation.

Colorectal Cancer Drugs Market Driver: Rising Demand For Personalized Medicines Drives Growth In Colorectal Cancer Drugs Market

The increasing demand for personalized medicines is expected tom propel the growth of the colorectal cancer drugs market going forward. Personalized medicine, also known as precision medicine, is an approach to medical treatment and healthcare that takes into account individual variations in patients' genes, environments, and lifestyles. Personalized medicine is transforming the approach to CRC treatment, offering more individualized and effective care for patients. It is likely to continue driving the growth of the CRC drug market as research and drug development efforts become more tailored to specific genetic and molecular profiles. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the colorectal cancer drugs market.

Colorectal Cancer Drugs Market Driver: Clinical Trials’ Pivotal Role In Advancing Colorectal Cancer Drug Market

The increasing number of clinical trials is expected to propel the growth of the colorectal cancer drugs market going forward. Clinical trials are research studies or experiments conducted with human volunteers to evaluate the safety and effectiveness of medical treatments, interventions, drugs, therapies, medical devices, or diagnostic procedures. Clinical trials are conducted to assess the safety and efficacy of new drug candidates specifically designed to treat colorectal cancer. These trials aim to identify novel therapies that can improve patient outcomes, which can lead to the introduction of new drugs into the market. For instance, in May 2023, according to Xtalks, a Canada-based digital health company, there were 452,604 clinical studies that had been registered on ClinicalTrials.gov as of May 17, 2023. 64,838 of the total number of registered studies are actively seeking participants. Compared to the more than 365,000 registered trials that were reported in early 2021, this is a considerable rise. Therefore, the increase in number of clinical trials is driving the growth of the colorectal cancer drugs market.

Global Colorectal Cancer Drugs Market Major Players

Major companies operating in the colorectal cancer drugs market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Danaher Corporation, Eli Lilly and Company, Amgen Inc., Siemens Healthineers AG, Astellas Pharma Inc., Servier Laboratories, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Ipsen SA, Taiho Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Metabiomics Corporation, Randox Laboratories, Taiho Oncology Inc., EDP Biotech Corporation, Genomic Tree Inc., Ono Pharmaceutical Co. Ltd., Epigenomics AG, Daiichi Sankyo Company Limited, Otsuka Pharmaceutical Co. Ltd., Mundipharma International Limited, Teva Pharmaceutical Industries Ltd., Biogen Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., Spectrum Pharmaceuticals Inc., Exelixis Inc., Seattle Genetics Inc., Incyte Corporation, Clovis Oncology Inc., Karyopharm Therapeutics Inc.

Global Colorectal Cancer Drugs Market Restraint: Impact Of Biologics And Targeted Therapies On The Bladder Cancer Drugs Market

The increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body’s immune system to fight cancer rather than chemical drugs which reduces the body’s immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective. For example, some targeted therapies that have been approved to treat colorectal cancer include bevacizumab, cetuximab, and panitumumab. The advantages of biological drugs and targeted therapies over conventional chemical drugs might negatively influence the growth of the colorectal cancer drugs market.

Global Colorectal Cancer Drugs Market Trend: Advancements In Targeted Therapies For Metastatic Colorectal Cancer

Targeted therapies have already begun to extend the lifespan of metastatic Colorectal cancer patients compared with chemotherapy-only therapy. Target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells while sparing the toxicity to off-target cells. Opdivo and Keytruda are examples of targeted therapies.

Global Colorectal Cancer Drugs Market Trend: FDA Approval Of Lonsurf (Trifluridine/Tipiracil) For Metastatic Colorectal Cancer Treatment

Major companies operating in the colorectal cancer drugs market are receiving FDA approvals for new drugs such as LONSURF (trifluridine/tipiracil) to increase their profitability in the market. LONSURF (trifluridine/tipiracil) is an oral medication that is only available by prescription and is used to treat specific cancers, such as colon, rectal, and stomach cancer that has spread to other regions of the body. For instance, in August 2023, Taiho Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company announced that Food and Drug Administration has approved LONSURF (trifluridine/tipiracil) combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (mCRC). In comparison to LONSURF alone, the combination of LONSURF with bevacizumab significantly increased both overall survival (OS) and progression-free survival (PFS). With a hazard ratio of 0.61 (95% CI: 0.49, 0.77; 1-sided p0.001), the median OS was 10.8 months in the LONSURF + bevacizumab arm and 7.5 months in the LONSURF arm.

Colorectal Cancer Drugs Market Merger And Acquisition:

Acquisition Of Mirati Therapeutics By Bristol-Myers Squibb To Enhance Oncology Portfolio With Krazati

In October 2023, The Bristol-Myers Squibb Company, a US-based pharmaceutical company acquired Mirati Therapeutics Inc for a deal amount of $5.8 Billion. The acquisition was made to add KRAZATI, a significant lung cancer drug, to Bristol Myers Squibb's commercial portfolio in order to improve and diversify the company's oncology portfolio. With the purchase, Mirati's therapies will be able to help more people, quicker, and will be able to fulfil the company's mission of uncovering the science that lies behind the promise of a life free from cancer. Mirati Therapeutics Inc is a US-based biotech company.

Regional Insights For The Global Colorectal Cancer Drugs Market

North America was the largest region in the colorectal cancer drugs market in 2023. The Middle East is expected to be the fastest-growing region in the global colorectal cancer drugs market share during the forecast period. The regions covered in the colorectal cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The colorectal cancer drugs market consists of sales of avastin, bevacizumab, and camptosar. Values in the colorectal cancer drugs market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The colorectal cancer drugs market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer drugs market statistics, including colorectal cancer drugs industry global market size, regional shares, competitors with a colorectal cancer drugs market share, detailed colorectal cancer drugs market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer drugs industry. This colorectal cancer drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Colorectal Cancer Drugs Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $20.74 billion
Revenue Forecast In 2033 $26.39 billion
Growth Rate CAGR of 6.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators
2) By Class: Immunotherapy, Chemotherapy, Other Classes
3) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Eli Lilly and Company; Amgen Inc.; Siemens Healthineers AG; Astellas Pharma Inc.; Servier Laboratories; Eisai Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Ipsen SA; Taiho Pharmaceutical Co. Ltd.; Kyowa Kirin Co. Ltd.; Metabiomics Corporation; Randox Laboratories; Taiho Oncology Inc.; EDP Biotech Corporation; Genomic Tree Inc.; Ono Pharmaceutical Co. Ltd.; Epigenomics AG; Daiichi Sankyo Company Limited; Otsuka Pharmaceutical Co. Ltd.; Mundipharma International Limited; Teva Pharmaceutical Industries Ltd.; Biogen Inc.; Gilead Sciences Inc.; Johnson & Johnson Services Inc.; Spectrum Pharmaceuticals Inc.; Exelixis Inc.; Seattle Genetics Inc.; Incyte Corporation; Clovis Oncology Inc.; Karyopharm Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Colorectal Cancer Drugs Market Characteristics

    3. Colorectal Cancer Drugs Market Trends And Strategies

    4. Colorectal Cancer Drugs Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Colorectal Cancer Drugs Market Size and Growth

    5.1. Global Colorectal Cancer Drugs Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Colorectal Cancer Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Colorectal Cancer Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Colorectal Cancer Drugs Market Segmentation

    6.1. Global Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Vascular Endothelial Growth Factor (VEGF) Inhibitors

    Epidermal Growth Factor Receptor (EGFR) Inhibitors

    Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

    BRAF or MEK Inhibitors

    Tyrosine Kinase (TKI) Inhibitors

    Immunomodulators

    6.2. Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Immunotherapy

    Chemotherapy

    Other Classes

    6.3. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals Pharmacies

    Retail Pharmacies

    Other Distribution Channels

    7. Colorectal Cancer Drugs Market Regional And Country Analysis

    7.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Colorectal Cancer Drugs Market

    8.1. Asia-Pacific Colorectal Cancer Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Colorectal Cancer Drugs Market

    9.1. China Colorectal Cancer Drugs Market Overview

    9.2. China Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Colorectal Cancer Drugs Market

    10.1. India Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Colorectal Cancer Drugs Market

    11.1. Japan Colorectal Cancer Drugs Market Overview

    11.2. Japan Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Colorectal Cancer Drugs Market

    12.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Colorectal Cancer Drugs Market

    13.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Colorectal Cancer Drugs Market

    14.1. South Korea Colorectal Cancer Drugs Market Overview

    14.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Colorectal Cancer Drugs Market

    15.1. Western Europe Colorectal Cancer Drugs Market Overview

    15.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Colorectal Cancer Drugs Market

    16.1. UK Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Colorectal Cancer Drugs Market

    17.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Colorectal Cancer Drugs Market

    18.1. France Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Colorectal Cancer Drugs Market

    19.1. Italy Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Colorectal Cancer Drugs Market

    20.1. Spain Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Colorectal Cancer Drugs Market

    21.1. Eastern Europe Colorectal Cancer Drugs Market Overview

    21.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Colorectal Cancer Drugs Market

    22.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Colorectal Cancer Drugs Market

    23.1. North America Colorectal Cancer Drugs Market Overview

    23.2. North America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Colorectal Cancer Drugs Market

    24.1. USA Colorectal Cancer Drugs Market Overview

    24.2. USA Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Colorectal Cancer Drugs Market

    25.1. Canada Colorectal Cancer Drugs Market Overview

    25.2. Canada Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Colorectal Cancer Drugs Market

    26.1. South America Colorectal Cancer Drugs Market Overview

    26.2. South America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Colorectal Cancer Drugs Market

    27.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Colorectal Cancer Drugs Market

    28.1. Middle East Colorectal Cancer Drugs Market Overview

    28.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Colorectal Cancer Drugs Market

    29.1. Africa Colorectal Cancer Drugs Market Overview

    29.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

    30.1. Colorectal Cancer Drugs Market Competitive Landscape

    30.2. Colorectal Cancer Drugs Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co. Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AbbVie Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bayer AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Colorectal Cancer Drugs Market Other Major And Innovative Companies

    31.1. Sanofi SA

    31.2. Bristol-Myers Squibb Company

    31.3. AstraZeneca plc

    31.4. Abbott Laboratories

    31.5. GlaxoSmithKline plc

    31.6. Takeda Pharmaceutical Company Limited

    31.7. F. Hoffmann-La Roche Ltd.

    31.8. Danaher Corporation

    31.9. Eli Lilly and Company

    31.10. Amgen Inc.

    31.11. Siemens Healthineers AG

    31.12. Astellas Pharma Inc.

    31.13. Servier Laboratories

    31.14. Eisai Co. Ltd.

    31.15. Sumitomo Dainippon Pharma Co. Ltd.

    32. Global Colorectal Cancer Drugs Market Competitive Benchmarking

    33. Global Colorectal Cancer Drugs Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

    35. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

    35.1 Colorectal Cancer Drugs Market In 2028 - Countries Offering Most New Opportunities

    35.2 Colorectal Cancer Drugs Market In 2028 - Segments Offering Most New Opportunities

    35.3 Colorectal Cancer Drugs Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Merck & Co. Inc. Financial Performance
  • Table 76: AbbVie Inc. Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Merck & Co. Inc. Financial Performance
  • Figure 76: AbbVie Inc. Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Novartis AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the colorectal cancer drugs market?

Colorectal cancer (CRC) or bowel cancer, is a type of cancer affecting the large intestine and the rectum. Depending on where they begin, they are also known as colon tumours or rectal cancer. For further insights on the colorectal cancer drugs market, request a sample here

How will the colorectal cancer drugs market drivers and restraints affect the colorectal cancer drugs market dynamics? What forces will shape the colorectal cancer drugs industry going forward?

The colorectal cancer drugs market major growth driver - rising demand for personalized medicines drives growth in colorectal cancer drugs market. For further insights on the colorectal cancer drugs market, request a sample here

What is the forecast market size or the forecast market value of the colorectal cancer drugs market ?

The colorectal cancer drugs market size has grown strongly in recent years. It will grow from $19.51 billion in 2023 to $20.74 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to integration of multimodal approaches, introduction of chemotherapy, advancements in surgical techniques, emergence of targeted therapies, clinical trials and research. The colorectal cancer drugs market size is expected to see strong growth in the next few years. It will grow to $26.39 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rise in personalized treatment, patient-centric care models, expansion of targeted therapies, adoption of combination therapies, regulatory acceleration. Major trends in the forecast period include immunotherapy advancements, precision medicine evolution, combination therapies, biomarker research and use, clinical trials innovation. For further insights on the colorectal cancer drugs market, request a sample here

How is the colorectal cancer drugs market segmented?

The colorectal cancer drugs market is segmented
1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators
2) By Class: Immunotherapy, Chemotherapy, Other Classes
3) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels For further insights on the colorectal cancer drugs market,
request a sample here

Which region has the largest share of the colorectal cancer drugs market? What are the other regions covered in the report?

North America was the largest region in the colorectal cancer drugs market in 2023. The Middle East is expected to be the fastest-growing region in the global colorectal cancer drugs market share during the forecast period. The regions covered in the colorectal cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the colorectal cancer drugs market, request a sample here.

Who are the major players in the colorectal cancer drugs market?

Major companies operating in the colorectal cancer drugs market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Danaher Corporation, Eli Lilly and Company, Amgen Inc., Siemens Healthineers AG, Astellas Pharma Inc., Servier Laboratories, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Ipsen SA, Taiho Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Metabiomics Corporation, Randox Laboratories, Taiho Oncology Inc., EDP Biotech Corporation, Genomic Tree Inc., Ono Pharmaceutical Co. Ltd., Epigenomics AG, Daiichi Sankyo Company Limited, Otsuka Pharmaceutical Co. Ltd., Mundipharma International Limited, Teva Pharmaceutical Industries Ltd., Biogen Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., Spectrum Pharmaceuticals Inc., Exelixis Inc., Seattle Genetics Inc., Incyte Corporation, Clovis Oncology Inc., Karyopharm Therapeutics Inc. For further insights on the colorectal cancer drugs market, request a sample here.

What are the key trends in the colorectal cancer drugs market?

Major trend in the colorectal cancer drugs market - advancements in targeted therapies for metastatic colorectal cancer. For further insights on the colorectal cancer drugs market, request a sample here.

What are the major opportunities in the colorectal cancer drugs market? What are the strategies for the colorectal cancer drugs market?

For detailed insights on the major opportunities and strategies in the colorectal cancer drugs market, request a sample here.

How does the colorectal cancer drugs market relate to the overall economy and other similar markets?

For detailed insights on colorectal cancer drugs market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the colorectal cancer drugs industry?

For detailed insights on the mergers and acquisitions in the colorectal cancer drugs industry, request a sample here.

What are the key dynamics influencing the colorectal cancer drugs market growth? SWOT analysis of the colorectal cancer drugs market.

For detailed insights on the key dynamics influencing the colorectal cancer drugs market growth and SWOT analysis of the colorectal cancer drugs industry, request a sample here.